- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-26-0095873

About Linq Therapeutics Private Limited
Data last updated:
Linq Therapeutics Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 29 September 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74999PN2015PTC156595. Its GSTIN is 27AACCL9382M1ZT (Maharashtra).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Pathik Pradeep Divate and Uma Pradeep Divate.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹95.69 Lakh, a decline of 26% compared to the previous year. For the same year it recorded a net profit of ₹3.25 Lakh (net margin 3.4%) and EBITDA of ₹7.5 Lakh (EBITDA margin 7.8%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 17% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Linq Labs.
Linq Therapeutics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0095873). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website linqlabs.com.
Company details
Recognitions & Rankings of Linq Therapeutics
Contact details
Linq Therapeutics Private Limited's registered office is in Pune, Maharashtra. Its website is linqlabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressOffice No. 309 – 311 Millenium Star, P 17 Fp 153 Cts 36 To 40 Sangamwadi, Pune, Maharashtra, India – 411001
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Linq Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Linq Therapeutics operates one associated brand: Linq Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Business IT solutions and accounting services for operations are provided. | linqlabs.com |
Business activity
The main business activity of Linq Therapeutics is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Linq Therapeutics Private Limited, buy the company report.
Financials of Linq Therapeutics Private Limited
FY 2025 filings availableLinq Therapeutics Private Limited reported revenue of ₹95.69 Lakh (down 26% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 26% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 17%. EBITDA fell 86% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.5 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.25 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.8% | ||||
| Net Profit Margin | 3.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Linq Therapeutics Private Limited, buy the company report.
Board of directors of Linq Therapeutics Private Limited
Linq Therapeutics has 5 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pathik Pradeep Divate Also directs: Jehangir Clinical Developement Centre Private Limited | Director | 29 Sep 2015 | 11 Years 1 Months | Current |
| Uma Pradeep Divate Also directs: Jehangir Clinical Developement Centre Private Limited | Director | 29 Sep 2015 | 11 Years 1 Months | Current |
| Cowasji Jehangir Jehangir Also directs: Cannadel Enterprises LLP, Jassim Properties LLP, Jehangir Brand Management Private Limited and 3 more | Director | 25 Nov 2020 | 5 Years 11 Months | Current |
| Jehangir Hirji Cawasji Jehangir Also directs: Goodearth Enterprises LLP, Cowhill Enterprises LLP, Cannadel Enterprises LLP and 5 more | Director | 29 Sep 2015 | 11 Years 1 Months | Current |
| Geeta Pathik Divate | Director | 25 Nov 2020 | 5 Years 11 Months | Current |
Auditor
Linq Therapeutics Private Limited is audited by PATANKAR & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PATANKAR & ASSOCIATES | FY 2019 | 107628W |
Shareholding
The shareholding of Linq Therapeutics Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Linq Therapeutics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Linq Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Linq Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Linq Therapeutics Private Limited has a workforce of 2 employees on its EPFO records as of Apr 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 2 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Linq Therapeutics Private Limited, buy the company report.
GST
Linq Therapeutics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCL9382M1ZT | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Linq Therapeutics Private Limited, buy the company report.
Recent activity
Linq Therapeutics Private Limited has 5 board changes on record since 2015: 5 appointments. The latest: Cowasji Jehangir Jehangir was appointed as Director on 25 Nov 2020.
Frequently asked questions
Linq Therapeutics is an active private limited company based in Pune, Maharashtra, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 29 September 2015 (11+ years old) and is registered under CIN U74999PN2015PTC156595.
Linq Therapeutics has 5 current directors:
- Pathik Pradeep Divate - Director
- Uma Pradeep Divate - Director
- Cowasji Jehangir Jehangir - Director
- Jehangir Hirji Cawasji Jehangir - Director
- Geeta Pathik Divate - Director
The latest financial statements of Linq Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Linq Therapeutics is 27AACCL9382M1ZT, registered in Maharashtra.
The CIN (Corporate Identification Number) of Linq Therapeutics is U74999PN2015PTC156595. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Linq Therapeutics was incorporated on 29 September 2015, making it 11+ years old. It is registered with the Registrar of Companies, Pune.
Cowasji Jehangir Jehangir was appointed as Director on 25 Nov 2020. Geeta Pathik Divate was appointed as Director on 25 Nov 2020. Jehangir Hirji Cawasji Jehangir was appointed as Director on 29 Sep 2015. Linq Therapeutics has 5 board changes on record in total.
Yes, Linq Therapeutics is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0095873).
Linq Therapeutics can be reached through the website linqlabs.com. Its registered office is in Pune, Maharashtra, India.
The registered office of Linq Therapeutics is at Office No. 309 – 311 Millenium Star, P 17 Fp 153 Cts 36 To 40 Sangamwadi, Pune, Maharashtra, India – 411001.

